Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep;4(9):634-40.

The emerging therapeutic role of probiotics in inflammatory bowel disease

Affiliations

The emerging therapeutic role of probiotics in inflammatory bowel disease

Matthew Chandler et al. Gastroenterol Hepatol (N Y). 2008 Sep.

Abstract

Nonpathogenic bacteria in a genetically susceptible individual play a suggestive role in the pathogenesis of inflammatory bowel disease (IBD). Probiotics are living organisms that exert a protective effect on intestinal mucosa. Although evidence supporting their use for inducing or maintaining remission of IBD remains limited, it may be reasonable to use probiotics as an adjunct to standard therapy for mild-to-moderate disease. Genetically modified probiotics may provide novel delivery methods of therapeutic payloads to inflamed intestinal mucosa. This review focuses on the emerging use of probiotics in the treatment of IBD.

Keywords: Crohn's disease; inflammatory bowel disease; pouchitis; probiotics; ulcerative colitis.

PubMed Disclaimer

References

    1. Sartor RB. Kirsner's Inflammatory Bowel Disease. 6th ed. Edinburgh: Elsevier; 2003. pp. 128–162.
    1. Biancone L, Monteleone I, Del Vecchio Blanco G, Vavassori P, Pallone F. Resident bacterial flora and immune system. Dig Liver Dis. 2002;34(suppl 2):S37–S43. - PubMed
    1. Jones J, Foxx-Orenstein A. The role of probiotics in inflammatory bowel disease. Dig Dis Sci. 2007;52:607–611. - PubMed
    1. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol. 1995;102:448–455. - PMC - PubMed
    1. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996;38:365–375. - PMC - PubMed

LinkOut - more resources